PKU HEALTHCARE CORP.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.91 CNY | +10.06% |
|
+24.42% | -11.92% |
| Apr. 26 | Pku Healthcare Corp.,Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
| Apr. 25 | PKU HealthCare Corp.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 2.08B 287M | Sales 2023 | 2.19B 303M | Capitalization | 4B 552M |
|---|---|---|---|---|---|
| Net income 2022 | 56M 7.73M | Net income 2023 | 44M 6.08M | EV / Sales 2022 | 1.95 x |
| Net cash position 2022 | 376M 51.9M | Net cash position 2023 | 375M 51.81M | EV / Sales 2023 | 1.65 x |
| P/E ratio 2022 |
79.2
x | P/E ratio 2023 |
90.2
x | Employees | 797 |
| Yield 2022 * |
-
| Yield 2023 |
0.39% | Free-Float | 60.66% |
More Fundamentals
* Assessed data
More news
| 1 day | +10.06% | ||
| 1 week | +24.42% | ||
| Current month | +8.64% | ||
| 1 month | +8.64% | ||
| 3 months | -0.51% | ||
| 6 months | -9.91% | ||
| Current year | -11.92% |
1 week
4.80
5.91
1 month
4.485.91
Current year
4.046.94
1 year
4.047.85
3 years
4.0415.40
5 years
4.0415.40
10 years
4.0422.75
| Managers | Title | Age | Since |
|---|---|---|---|
Quan Bo Zhao
DFI | Director of Finance/CFO | 53 | 16-03-01 |
Ping Dong Yuan
PSD | President | 56 | 16-03-01 |
Bi Cheng Zhang
BRD | Director/Board Member | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jing Yu Jin
BRD | Director/Board Member | 58 | 02-06-30 |
Jin Song Song
CHM | Chairman | 57 | 17-08-28 |
Run Mao
BRD | Director/Board Member | 58 | 17-03-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.32% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 5.91 | +10.06% | 29,097,020 |
| 24-04-29 | 5.37 | -0.37% | 20,131,760 |
| 24-04-26 | 5.39 | +7.58% | 30,586,200 |
| 24-04-25 | 5.01 | +2.66% | 6,375,200 |
| 24-04-24 | 4.88 | -.--% | 5,200,600 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
PKU HealthCare Corp., Ltd. is a China-based company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. The Company is also engaged in the pharmaceutical distribution business and the provision of related medical services. The Company's main pharmaceutical preparations include digestive, cardiovascular, endocrine, anti-infective, central nervous, analgesic and other preparations. The Company mainly conducts its business in domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -11.92% | 486M | |
| +33.25% | 699B | |
| +28.59% | 571B | |
| -3.55% | 364B | |
| +18.16% | 326B | |
| +4.36% | 286B | |
| +14.81% | 236B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.69% | 149B |
- Stock Market
- Equities
- 000788 Stock
